ConductScience.org, home

Library / Trial comparisons

Targeted Oral Azithromycin vs Targeted Oral Placebo: All-cause Mortality Rate in Individually Randomized Children at 4-12 Weeks of Age

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measures 6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNoteSource
Risk in group 10.005210.00420.00646wilsonClinicalTrials.gov
Risk in group 20.004780.003810.00598wilsonClinicalTrials.gov
Risk difference, group 1 minus group 20.000435-0.001140.00202newcombe hybrid scoreClinicalTrials.gov
Risk ratio, group 1 over group 21.090.7981.49logClinicalTrials.gov
Odds ratio, group 1 over group 21.090.7971.49logClinicalTrials.gov
Number needed to treat, for one more participant with the outcome on Targeted Oral Azithromycin than on Targeted Oral Placebo2,300from the risk difference intervalthe interval includes no differenceClinicalTrials.gov

Groups 2

Group 2 names the comparator: placebo.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov codeSource
Group 1Targeted Oral Azithromycin
Targeted azithromycin to children 5 to 12 weeks old at vaccine visit or other healthy child visit~Azithromycin: biannual azithromycin in eligible communities to children 1 to 59 months old Targeted azithromycin to children aged 5 to 8 weeks old at the vaccine visit
8215,734OG000ClinicalTrials.gov
Group 2Targeted Oral Placebo
Targeted placebo to children 5 to 12 weeks old at vaccine visit or other healthy child visit~Placebos: biannual placebo in eligible communities to children 1 to 59 months old Targeted placebo to children aged 5 to 8 weeks old at the vaccine visit
7515,701OG001ClinicalTrials.gov

Outcome 5

FieldValueSource
TypePRIMARYClinicalTrials.gov
TitleAll-cause Mortality Rate in Individually Randomized Children at 4-12 Weeks of AgeClinicalTrials.gov
DescriptionAll-cause mortality as determined by a follow-up visit for individually randomized children at healthy child visitsClinicalTrials.gov
Time frame6 monthsClinicalTrials.gov
PopulationClinicalTrials.gov

Trial 8

FieldValueSource
TitleCommunity Health Azithromycin Trial in Burkina FasoClinicalTrials.gov
NCT numberNCT03676764ClinicalTrials.gov
PhasesPHASE4ClinicalTrials.gov
ConditionsChildhood MortalityClinicalTrials.gov
InterventionsAzithromycin, PlacebosClinicalTrials.gov
Lead sponsorUniversity of California, San FranciscoClinicalTrials.gov
Results first posted2025-02-24ClinicalTrials.gov
Results on ClinicalTrials.govhttps://clinicaltrials.gov/study/NCT03676764?tab=resultsClinicalTrials.gov

Source 4

FieldValueSource
Releasetrial-comparisons-2026-03-23-0.1.0ClinicalTrials.gov
Release manifest SHA-256f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57ClinicalTrials.gov
AACT copy2026-03-23ClinicalTrials.gov
Tables readoutcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquetClinicalTrials.gov

The same record as JSON

Release trial-comparisons-2026-03-23-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.